RXRXCAUTIOUS

RXRX Gross Margin Analysis

-93.0%

Higher than 3% of Healthcare sector peers

Updated 2555h ago·SEC filings & market data

Key Takeaway

RXRX (RXRX) has a Gross Margin of -93.0% as of May 2026.

Sector Performance

3th percentile

RXRX

-93.0%

Sector Median

68.3%

Sector Avg

-55.4%

📊

Deep Analysis

RXRX (RXRX) has a Gross Margin of -93.0% as of May 2026.

This places RXRX in the 3th percentile of the Healthcare sector, which has a median Gross Margin of 68.3% and a sector average of -55.4%. RXRX's Gross Margin is 236.2% below the sector median, a significant divergence that warrants closer examination. In context: Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Frequently Asked Questions

What does the Gross Margin tell investors about RXRX?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does RXRX's Gross Margin compare to its sector?

RXRX's Gross Margin of -93.0% compares to a Healthcare sector median of 68.3%, placing it in the 3th percentile.

Who are RXRX's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), BLUE (68.4%), TECH (66.9%), EXAS (70.1%), ALGN (70.8%).

📚

Learn More About Gross Margin

Gross Margin vs Net Margin: Why the Gap Between Them Tells You Everything

Gross margin vs net margin: learn what the spread between them reveals about operating leverage, cost structure, and early warning signs in any stock.

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.